Clinical Trial Update: Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE) [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial updating safety of acamprosate for alcohol dependence in the elderly; study withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: University of New Mexico | Conditions: Alcohol Dependence | Phase 4 | Status: WITHDRAWN